Pecks U, Bohlmann MK, Andresen K, Büchel J, Bartmann C, Sitter M, Tihon A, Kranke P, Wöckel A, Hollweck R, Dressler-Steinbach I, Gruessner S, Gruber TM, Eichinger T, Manz J, Ruehl IM, Lihs A, Biermann AL, Bauerfeind LM, Oberste KM, Ramsauer B, Russe E, Schrey-Petersen S, Erol FM, Birdir C, Kaup L, Seliger G, Morfeld C, Berghaeuser MA, Richter MF, Jakubowski P, Linnemann B, Rath W. SARS-CoV-2 infection in pregnant women and incidence of thromboembolic disease: an analysis of the Covid-19-Related Obstetric and Neonatal Outcome Study (CRONOS) in Germany.
Arch Gynecol Obstet 2025:10.1007/s00404-025-08007-5. [PMID:
40131456 DOI:
10.1007/s00404-025-08007-5]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2025] [Accepted: 03/10/2025] [Indexed: 03/27/2025]
Abstract
PURPOSE
The aim of the present study was to quantify the rate of thromboembolic events (TE) in pregnant women with SARS-CoV-2 infection and to characterize risk factors to provide a basis for individualized recommendation on prophylactic measures.
METHODS
CRONOS is a multicenter, prospective observational study conducted in Germany and Austria during the COVID-19 pandemic. Pregnant women with confirmed SARS-CoV-2 infection were enrolled. Data on demographics, medical history, COVID-19-related aspects, and pregnancy and birth outcomes were collected. TE was particularly queried and used as the primary outcome. A combination of "TE," "maternal or fetal death," or "severe postpartum hemorrhage" was defined as a secondary endpoint. Risk analyses were performed using univariate and multivariable logistic regression models.
RESULTS
Data from 8033 pregnant patients showed 40 TEs (0.5% incidence). TE rates were 10% in ICU patients, 0.2-0.4% in those with moderate-to-mild COVID-19, and < 0.1% in asymptomatic women. Pulmonary embolism occurred in 21 cases, deep vein thrombosis in 12, and 7 had atypical or arterial TE. Risk factors included advanced gestational age, COVID-19 symptoms, hospitalization or ICU admission, premature birth, cesarean section, delivery within 4 weeks of infection, higher weight gain, anemia, and chronic inflammatory bowel disease. COVID-19 vaccination reduced risk. The logistic risk model yielded an AUC of 0.87 (95% CI 0.81-0.94).
CONCLUSION
The TE rate in pregnant women is largely determined by the severity of the disease. In asymptomatic or mild cases, other factors outweigh TE risk, while severe COVID-19 requiring ICU admission poses a high TE risk despite prophylaxis.
Collapse